SGYP Synergy Pharmaceuticals, Inc.

6.07
+0.01  (0.17%)
Previous Close 6.06
Open 6.08
Price To book 90.45
Market Cap 1.09B
Shares 179,953,000
Volume 4,808,205
Short Ratio 4.19
Av. Daily Volume 6,231,770

Drug Information

Drug catalyst information is displayed when you hover over the stage bar graph.

Phase 3 data from first and second trials met primary endpoints - December 9 and 22, 2016. NDA filing due 1Q 2017.
Plecanatide
Constipation-predominant irritable bowel syndrome (IBS-C)
Approved January 19, 2017.
Trulance (plecanatide)
Chronic idiopathic constipation (CIC)
Phase 1b data released January 2016. Phase 2 planned.
Dolcanatide
Mild-to-moderate ulcerative colitis

Latest News

  1. SYNERGY PHARMACEUTICALS, INC. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits
  2. SYNERGY PHARMACEUTICALS, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits
  3. Synergy Pharmaceuticals to Present at Leerink Partners 6th Annual Global Healthcare Conference
  4. SYNERGY PHARMACEUTICALS, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits
  5. Pivotal Phase 3 Data Results for TRULANCE™ (plecanatide) in the Treatment of Chronic Idiopathic Constipation (CIC) Published in American Journal of Gastroenterology
  6. Price For Synergy Pharmaceuticals Inc (SGYP) Public Offering Announced
  7. SYNERGY PHARMACEUTICALS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Other Events, Financial
  8. Why Synergy Pharmaceuticals Shares Fell 14.6% Today
  9. How to Trade Hot Stocks Apple, Seadrill, Advanced Micro Devices
  10. Fail, win and then fail some more to become a winning trader
  11. The Zacks Analyst Blog Highlights: Synergy Pharmaceuticals, Amgen, Valeant Pharmaceuticals International, Celgene and Lexicon Pharmaceuticals
  12. Premarket Biotech Movers: Synergy, Arrowhead, BioCryst
  13. Synergy Pharma stock sinks 12.5% after announcement of common stock offering
  14. Synergy Pharmaceuticals Announces Pricing of Public Offering of Common Stock
  15. Synergy Pharmaceuticals Announces Proposed Public Offering of Common Stock
  16. 4 FDA Decisions to Watch Out for in Feb 2017
  17. 5 Small-Cap Biotech Stocks to Buy in February
  18. FDA Approves Trulance From Synergy Pharmaceuticals Inc (SGYP) To Battle With Allergan PLC (AGN) Linzess
  19. UPDATE 1-Synergy wins U.S. approval for constipation drug (Jan 19)
  20. Are Options Traders Betting on a Big Move in Synergy Pharmaceuticals (SGYP) Stock?